Home > Publications Database > Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers. > print

001     257587
005     20240722121855.0
024 7 _ |a pmc:PMC10334300
|2 pmc
024 7 _ |a 10.1002/mds.29337
|2 doi
024 7 _ |a pmid:36788297
|2 pmid
024 7 _ |a 0885-3185
|2 ISSN
024 7 _ |a 1531-8257
|2 ISSN
024 7 _ |a altmetric:142558252
|2 altmetric
037 _ _ |a DZNE-2023-00463
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Sugier, Pierre-Emmanuel
|0 0000-0002-5846-1104
|b 0
245 _ _ |a Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers.
260 _ _ |a New York, NY
|c 2023
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1721636575_12030
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Epidemiological studies that examined the association between Parkinson's disease (PD) and cancers led to inconsistent results, but they face a number of methodological difficulties.We used results from genome-wide association studies (GWASs) to study the genetic correlation between PD and different cancers to identify common genetic risk factors.We used individual data for participants of European ancestry from the Courage-PD (Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease; PD, N = 16,519) and EPITHYR (differentiated thyroid cancer, N = 3527) consortia and summary statistics of GWASs from iPDGC (International Parkinson Disease Genomics Consortium; PD, N = 482,730), Melanoma Meta-Analysis Consortium (MMAC), Breast Cancer Association Consortium (breast cancer), the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (prostate cancer), International Lung Cancer Consortium (lung cancer), and Ovarian Cancer Association Consortium (ovarian cancer) (N comprised between 36,017 and 228,951 for cancer GWASs). We estimated the genetic correlation between PD and cancers using linkage disequilibrium score regression. We studied the association between PD and polymorphisms associated with cancers, and vice versa, using cross-phenotypes polygenic risk score (PRS) analyses.We confirmed a previously reported positive genetic correlation of PD with melanoma (Gcorr = 0.16 [0.04; 0.28]) and reported an additional significant positive correlation of PD with prostate cancer (Gcorr = 0.11 [0.03; 0.19]). There was a significant inverse association between the PRS for ovarian cancer and PD (odds ratio [OR] = 0.89 [0.84; 0.94]). Conversely, the PRS of PD was positively associated with breast cancer (OR = 1.08 [1.06; 1.10]) and inversely associated with ovarian cancer (OR = 0.95 [0.91; 0.99]). The association between PD and ovarian cancer was mostly driven by rs183211 located in an intron of the NSF gene (17q21.31).We show evidence in favor of a contribution of pleiotropic genes to the association between PD and specific cancers. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Parkinson's disease
|2 Other
650 _ 7 |a cancer
|2 Other
650 _ 7 |a genetic correlation
|2 Other
650 _ 7 |a pleiotropy
|2 Other
650 _ 7 |a polygenic risk score
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Parkinson Disease: epidemiology
|2 MeSH
650 _ 2 |a Parkinson Disease: genetics
|2 MeSH
650 _ 2 |a Genome-Wide Association Study
|2 MeSH
650 _ 2 |a Genetic Predisposition to Disease: genetics
|2 MeSH
650 _ 2 |a Polymorphism, Single Nucleotide: genetics
|2 MeSH
650 _ 2 |a Melanoma: epidemiology
|2 MeSH
650 _ 2 |a Melanoma: genetics
|2 MeSH
650 _ 2 |a Prostatic Neoplasms
|2 MeSH
650 _ 2 |a Ovarian Neoplasms
|2 MeSH
650 _ 2 |a Risk Factors
|2 MeSH
650 _ 2 |a Lung Neoplasms
|2 MeSH
700 1 _ |a Lucotte, Elise A
|b 1
700 1 _ |a Domenighetti, Cloé
|0 0000-0001-6408-0351
|b 2
700 1 _ |a Law, Matthew H
|b 3
700 1 _ |a Iles, Mark M
|b 4
700 1 _ |a Brown, Kevin
|b 5
700 1 _ |a Amos, Christopher
|b 6
700 1 _ |a McKay, James D
|b 7
700 1 _ |a Hung, Rayjean J
|b 8
700 1 _ |a Karimi, Mojgan
|b 9
700 1 _ |a Bacq-Daian, Delphine
|b 10
700 1 _ |a Boland-Augé, Anne
|b 11
700 1 _ |a Olaso, Robert
|b 12
700 1 _ |a Deleuze, Jean-François
|b 13
700 1 _ |a Lesueur, Fabienne
|b 14
700 1 _ |a Ostroumova, Evgenia
|b 15
700 1 _ |a Kesminiene, Ausrele
|b 16
700 1 _ |a de Vathaire, Florent
|b 17
700 1 _ |a Guénel, Pascal
|b 18
700 1 _ |a consortium, EPITHYR
|b 19
|e Collaboration Author
700 1 _ |a Sreelatha, Ashwin Ashok Kumar
|b 20
700 1 _ |a Schulte, Claudia
|0 P:(DE-2719)9000366
|b 21
|u dzne
700 1 _ |a Grover, Sandeep
|0 0000-0003-2615-4916
|b 22
700 1 _ |a May, Patrick
|0 0000-0001-8698-3770
|b 23
700 1 _ |a Bobbili, Dheeraj R
|0 0000-0002-1368-9623
|b 24
700 1 _ |a Radivojkov-Blagojevic, Milena
|b 25
700 1 _ |a Lichtner, Peter
|b 26
700 1 _ |a Singleton, Andrew B
|b 27
700 1 _ |a Hernandez, Dena Michelle Godwin
|0 P:(DE-2719)2812102
|b 28
|u dzne
700 1 _ |a Edsall, Connor
|b 29
700 1 _ |a Mellick, George D
|b 30
700 1 _ |a Zimprich, Alexander
|0 0000-0002-1668-5177
|b 31
700 1 _ |a Pirker, Walter
|b 32
700 1 _ |a Rogaeva, Ekaterina
|b 33
700 1 _ |a Lang, Anthony E
|0 0000-0003-1229-3667
|b 34
700 1 _ |a Koks, Sulev
|b 35
700 1 _ |a Taba, Pille
|b 36
700 1 _ |a Lesage, Suzanne
|b 37
700 1 _ |a Brice, Alexis
|b 38
700 1 _ |a Corvol, Jean-Christophe
|0 0000-0001-7325-0199
|b 39
700 1 _ |a Chartier-Harlin, Marie-Christine
|b 40
700 1 _ |a Mutez, Eugénie
|0 0000-0002-5947-0432
|b 41
700 1 _ |a Brockmann, Kathrin
|0 P:(DE-2719)2811916
|b 42
700 1 _ |a Deutschländer, Angela B
|0 0000-0003-2152-9926
|b 43
700 1 _ |a Hadjigeorgiou, Georges M
|b 44
700 1 _ |a Dardiotis, Efthimios
|b 45
700 1 _ |a Stefanis, Leonidas
|0 0000-0003-3569-8990
|b 46
700 1 _ |a Simitsi, Athina Maria
|b 47
700 1 _ |a Valente, Enza Maria
|0 0000-0002-0600-6820
|b 48
700 1 _ |a Petrucci, Simona
|b 49
700 1 _ |a Straniero, Letizia
|b 50
700 1 _ |a Zecchinelli, Anna
|b 51
700 1 _ |a Pezzoli, Gianni
|b 52
700 1 _ |a Brighina, Laura
|b 53
700 1 _ |a Ferrarese, Carlo
|b 54
700 1 _ |a Annesi, Grazia
|b 55
700 1 _ |a Quattrone, Andrea
|0 P:(DE-2719)9002627
|b 56
|u dzne
700 1 _ |a Gagliardi, Monica
|b 57
700 1 _ |a Matsuo, Hirotaka
|b 58
700 1 _ |a Nakayama, Akiyoshi
|b 59
700 1 _ |a Hattori, Nobutaka
|b 60
700 1 _ |a Nishioka, Kenya
|b 61
700 1 _ |a Chung, Sun Ju
|0 0000-0003-4118-8233
|b 62
700 1 _ |a Kim, Yun Joong
|b 63
700 1 _ |a Kolber, Pierre
|b 64
700 1 _ |a van de Warrenburg, Bart P C
|b 65
700 1 _ |a Bloem, Bastiaan R
|b 66
700 1 _ |a Aasly, Jan
|b 67
700 1 _ |a Toft, Mathias
|0 0000-0002-6723-6865
|b 68
700 1 _ |a Pihlstrøm, Lasse
|b 69
700 1 _ |a Guedes, Leonor Correia
|b 70
700 1 _ |a Ferreira, Joaquim J
|0 0000-0003-3950-5113
|b 71
700 1 _ |a Bardien, Soraya
|0 0000-0002-3508-3438
|b 72
700 1 _ |a Carr, Jonathan
|b 73
700 1 _ |a Tolosa, Eduardo
|0 0000-0002-3781-0854
|b 74
700 1 _ |a Ezquerra, Mario
|0 0000-0003-3246-6641
|b 75
700 1 _ |a Pastor, Pau
|b 76
700 1 _ |a Diez-Fairen, Monica
|b 77
700 1 _ |a Wirdefeldt, Karin
|b 78
700 1 _ |a Pedersen, Nancy
|b 79
700 1 _ |a Ran, Caroline
|b 80
700 1 _ |a Belin, Andrea C
|b 81
700 1 _ |a Puschmann, Andreas
|b 82
700 1 _ |a Rödström, Emil Ygland
|b 83
700 1 _ |a Clarke, Carl E
|b 84
700 1 _ |a Morrison, Karen E
|b 85
700 1 _ |a Tan, Manuela
|0 0000-0001-5835-669X
|b 86
700 1 _ |a Krainc, Dimitri
|b 87
700 1 _ |a Burbulla, Lena F
|0 P:(DE-2719)9000040
|b 88
|u dzne
700 1 _ |a Farrer, Matt J
|b 89
700 1 _ |a Kruger, Rejko
|0 P:(DE-2719)2811170
|b 90
|u dzne
700 1 _ |a Gasser, Thomas
|0 P:(DE-2719)2320009
|b 91
|u dzne
700 1 _ |a Sharma, Manu
|0 P:(DE-2719)9000296
|b 92
|u dzne
700 1 _ |a Genetics, Comprehensive Unbiased Risk Factor Assessment for
|b 93
700 1 _ |a Disease, Environment in Parkinson's
|b 94
|e Collaboration Author
700 1 _ |a Truong, Thérèse
|b 95
700 1 _ |a Elbaz, Alexis
|0 0000-0001-9724-5490
|b 96
773 _ _ |a 10.1002/mds.29337
|g Vol. 38, no. 4, p. 604 - 615
|0 PERI:(DE-600)2041249-6
|n 4
|p 604 - 615
|t Movement disorders
|v 38
|y 2023
|x 0885-3185
856 4 _ |u https://pub.dzne.de/record/257587/files/DZNE-2023-00463%20SUP.doc
856 4 _ |u https://pub.dzne.de/record/257587/files/DZNE-2023-00463%20SUP.docx
856 4 _ |u https://pub.dzne.de/record/257587/files/DZNE-2023-00463%20SUP.odt
856 4 _ |u https://pub.dzne.de/record/257587/files/DZNE-2023-00463%20SUP.pdf
856 4 _ |u https://pub.dzne.de/record/257587/files/DZNE-2023-00463.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/257587/files/DZNE-2023-00463.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:257587
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 21
|6 P:(DE-2719)9000366
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 28
|6 P:(DE-2719)2812102
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 42
|6 P:(DE-2719)2811916
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 56
|6 P:(DE-2719)9002627
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 88
|6 P:(DE-2719)9000040
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 90
|6 P:(DE-2719)2811170
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 91
|6 P:(DE-2719)2320009
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 92
|6 P:(DE-2719)9000296
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 1
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-11
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2022-11-11
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-11
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-24
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOVEMENT DISORD : 2022
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-24
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-24
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b MOVEMENT DISORD : 2022
|d 2023-10-24
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 0
920 1 _ |0 I:(DE-2719)5000074
|k AG Burbulla
|l Translational Disease Modeling
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a I:(DE-2719)5000074
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21